ReviewInternational journal of molecular sciences2024

Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge.

Clara Martínez-Vila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.